Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Izalontamab |
Synonyms | |
Therapy Description |
Izalontamab (SI-B001) is a bispecific antibody targeting EGFR and ERBB3 (HER3), which potentially inhibits tumor growth (PMID: 32565357). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Izalontamab | SI-B001|SI B001|SIB001 | EGFR Antibody 60 HER3 (ERBB3) Antibody 23 | Izalontamab (SI-B001) is a bispecific antibody targeting EGFR and ERBB3 (HER3), which potentially inhibits tumor growth (PMID: 32565357). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|